Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AKVA group ASA: Letter of Intent with Cermaq Chile
-
Juniper Research Finds Global Enterprise Losses to AIT - Artificially Inflated Traffic - to Halve Over Next Five Years
-
TOKYO SKYTREE Offers Special Tours for Inbound Visitors to Enjoy Japanese Culture Such as Geisha and Sumo on Observation Deck Open Exclusively for Tour Participants
-
Groundbreaking Research Proves Bicycles Power Economic Growth and Healthcare Access
-
Little Lion Entertainment Selects accesso® for Ticketing and Distribution
-
Seamless Therapeutics to Present New Data at ESGCT Demonstrating its Ability to Reprogram Large Serine Recombinases to Specific Target Sites in the Human Genome
-
NICE Expands CXone Mpower – The Ultimate AI Hyper Platform for Customer Service Automation
-
Cornish Metals Grant of Options & PDMR Dealings
-
Ring Therapeutics Presents Preclinical Data on Anellogy™ Platform at the 31st Annual European Society of Gene & Cell Therapy Conference
-
Epicrispr Biotechnologies Presents Data on Powerful Gene Reactivation with GEMS Epigenetic Editors at ESGCT
-
Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress
-
Agillic releases Q3 2024 financial report with 8% decrease in ARR from Subscriptions YoY, EBITDA of DKK 1.8 million and DKK 6.7 million in cash flow from operations
-
Egide: results for the 1st half of 2024 - Philippe BENSUSSAN appointed Chairman - New Capital Increase
-
Volta Finance Limited Annual Financial Report and Notice of Annual General Meeting
-
Innofactor Plc: Cancellation of treasury shares
-
Transaction in Own Shares
-
Marimekko and UNIQLO celebrate autumnal moments with limited-edition Fall/Winter 2024 collection
-
Extension of the cruise ferry Galaxy I charter agreement
-
Skanska signs additional contract to expand hospital in Astoria, Oregon, USA for USD 153M, about SEK 1.6 billion
-
SASOL LIMITED: PRODUCTION AND SALES METRICS FOR THE THREE MONTHS ENDED 30 SEPTEMBER 2024
-
HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure
-
Embla Medical hf: Interim Report Q3 2024
-
Going Big! Podcast Reaches #2 on iTunes, Today’s Episode Features the Inspiring Story of Daniel Di Martino
-
Wendel announces a transformational transaction in line with its strategic roadmap
-
Monroe Capital to Enter into Strategic Partnership with Wendel Group
-
Crossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization
-
Exosens announces agreement to acquire NVLS (Night Vision Laser Spain), specialist in night vision equipment
-
BW Energy: Q3 2024 trading update
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Sampo plc’s share buybacks 21 October 2024
-
Eurofins Confirms Profitability and Cash Flow Objectives for 2024 Leading to Higher Profit Margins in Spite of the Impact of the Post-COVID Reset of BioPharma Pipelines
-
Eurofins Announces Results of Cash Audit Confirming Its FY 2023 Cash Balance and the High Integrity of Its Systems and Controls and Refutes Muddy Waters’ Allegations Regarding Transactions That Occu
-
ZEEKR to Report Third Quarter 2024 Financial Results on November 14, 2024
-
Tecan’s Capital Markets Day highlights strategic growth drivers, groundbreaking innovation and product launches
-
Behavioural Science Research Reveals Key Spending Drivers for Airline Passengers in 2025
-
Mack International Introduces Brian Adams as Partner of their Leadership Team Shaping Future of the Family Office Industry
-
CyberSecurity Breakthrough Awards Names Portnox Policy Management Solution Provider of the Year
-
TrueDialog Announces SMS Application for Salesforce Marketing Cloud Engagement, Integrating Seamlessly with the Salesforce Cloud Ecosystem
-
Kaishan Recognized with Frost & Sullivan's 2024 Global Competitive Strategy Leadership Award for Its Outstanding Contributions to the Industrial Air Compressor Industry
-
BioVersys Joins EU-Funded RespiriNTM Programme to Accelerate Development of Its Broad-Spectrum Drug Candidates Against NTM Pulmonary Diseases
-
Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics
-
Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024
-
Start of Day Message
-
LHV Group’s unaudited financial results for Q3 and nine months of 2024
-
eQ Plc’s interim report Q3 2024 – eQ’s operating profit EUR 27.6 million
-
Balchug Capital Welcomes Leading Sanctions and AML Expert as Counsel to its Global Advisory Board
-
Everest Medicines Announces Positive Results of Complete Chinese Subpopulation Data from the NEFECON Global Phase 3 NefIgArd Clinical Trial
-
BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
-
HONOR Magic7 Series to Introduce Autopilot AI for Mobile


